Luís Fardilha

📢 Medical Devices Update: New Guidelines for Medical Device Labeling! 🌐 The International Medical Device Regulators Forum (IMDRF) has released a new document outlining the principles of labeling for medical devices, including those for in-vitro diagnostics (IVDs). 👉 This document aims to standardize the content and format of medical device labeling, which can be presented in paper or electronic form. It covers general labeling principles and includes specific sections on the label itself, instructions for use, and patient information. 👉 It’s important to note that this document provides general guidelines and doesn’t cover everything. Manufacturers should also consider the requirements of any relevant medical device or IVD medical device-specific standards. Additionally, advertising and promotional materials are not included in the scope of this document, and individual regulatory authorities may have their own requirements for these elements. 💡 This new guidance promotes clear and consistent labeling for medical devices worldwide, which can ultimately improve patient safety and device use. 🔎 Know more about our expertise for medical devices and IVDs labeling at: https://lnkd.in/dt4tQYNy

The International Medical Device Regulators Forum (IMDRF) has just released a new final document! This latest document, IMDRF/GRRP WG/N71, is part of a series aimed at streamlining the regulatory approval process for medical devices. Building upon existing guidelines, it focuses on the crucial aspect of regulatory review reports. By specifying the information that should be included in these reports, IMDRF/GRRP WG/N71 ensures a standardized approach across regulatory jurisdictions. This not only promotes efficiency but also enhances collaboration between review bodies and regulatory authorities. At Medical Devices Regulatory — support unit (MDRu) we understand the importance of staying up-to-date with regulatory updates like IMDRF/GRRP WG/N71. Visit our website to learn more about how we can assist you in navigating these changes and ensuring compliance with regulatory requirements: https://lnkd.in/dt4tQYNy Let’s work together to drive innovation while maintaining the highest standards of safety and performance in the medical device industry!

A quick look back at our recent webinar “Software as a Medical Device and the Regulatory Implications of AI,” where Sandra Balseiro and Ana Brito shared their expertise:Sandra Balseiro delved into European Regulation for Software as a Medical Device, providing strategic insights to streamline the regulatory approval process.Ana Brito shared her experience and valuable insights about European Regulation and the AI ACT.Also, Eduardo Barbosa and Inês Lopes transmitted the good practices for software as a medical device and AI softwareAdditionally, Miguel Mascarenhas, CEO of DIGESTAID – Digestive Artificial Intelligence Development, present “The real set case of DIGESTAID – Digestive Artificial Intelligence Development.”Thank you to all our speakers and participants for an enriching discussion!

Exciting News! The new version of EUDAMED 3.8.0 has been deployed! For all the details on what’s new and improved in this release, check out the full release note document available at the EUDAMED Information Centre – EUDAMED (playground). Read the full release note: EUDAMED release note (v3.8) The MDRu can help you navigate these updates and ensure your compliance. Visit our website to learn how we can support your regulatory needs and keep your medical devices market-ready. Visit our website: https://lnkd.in/dreiWTp7

A quick look at the webinar ‘Mastering the Clinical Evaluation of Medical Devices’, which took place last week! Sandra Balseiro and Celeste Oliveira, from MDRu, provided an in-depth understanding of the regulatory requirements for clinical evaluation. Insights from the CRO, NOVA Clinical Research Unit (NOVA CRU), helped attendees navigate the clinical evaluation process. In addition, João Leite shared Insparya Portugal‘s first-hand experience. This was the third in a series of webinars designed to enhance knowledge of medical device regulations: “Understanding Medical Devices Regulation”, “Software as a Medical Device and the Regulatory Implications of AI”, and “Mastering the Clinical Evaluation of Medical Devices.”

EU gives final green light to the first worldwide rules on AIThe EU Council has approved the Artificial Intelligence (AI) Act, establishing the world’s first comprehensive AI rules. This landmark legislation uses a risk-based approach, imposing stricter regulations on high-risk AI to protect society and fundamental rights.Key Points:– Risk-Based Regulation: Stricter rules for higher-risk AI systems.– Fundamental Rights: Ensures AI respects EU citizens’ rights.– Governance: New bodies to enforce and support AI rules.– Innovation Support: Regulatory sandboxes for testing AI systems.– Transparency: Mandatory impact assessments and registration for high-risk AI.Read more here: https://lnkd.in/dfZqbE_jAt MDRu we can help you with the AI Act, see how through the website: https://lnkd.in/dreiWTp7

Medical Devices Update: Council adopts new measures to help prevent shortages! The European Council recently updated regulations on medical devices to address potential shortages and improve transparency. These changes aim to strike a balance between ensuring device safety and facilitating market access. Firstly, the transition period for certain in-vitro diagnostic medical devices (IVDs) has been extended. This ensures continued availability of critical IVDs while new safety regulations are implemented. Secondly, the rollout of the European database on medical devices (EUDAMED) will be gradual. Manufacturers can begin registering devices in existing modules without waiting for the entire system to be complete. Full mandatory registration is expected by late 2025. Finally, manufacturers are now required to provide advanced notice of potential supply disruptions for critical medical devices and IVDs. This will allow relevant authorities and healthcare providers to prepare and potentially mitigate shortages. Visit our website to find out how we can help you to be compliant in this field: https://lnkd.in/dreiWTp7

MDRU attended the Hospitalar 2024, in Brazil, a renowned Hospitalar trade fair!We are dedicated to advancing the medical device and IVD sector through comprehensive regulatory support. Our presence at the fair allowed us to engage directly with Brazilian companies eager to expand their business into Europe.We are committed to bridging the gap between markets by providing regulatory assistance to both Brazilian companies aiming to enter the European market and European companies looking to bring their innovations to Brazil.Discover how MDRu can support your business by visiting our website: https://lnkd.in/dt4tQYNy

The US FDA, Health Canada, and UK MHRA released a new document today: “Transparency for Machine Learning-Enabled Medical Devices: Guiding Principles.” This builds on the 2021 Good Machine Learning Practice (GMLP) principles, providing additional considerations for developers and regulators on ensuring transparency in AI-powered medical devices. These principles are key for fostering trust and responsible development in this rapidly evolving field. Find out more about MDRu at: https://lnkd.in/dreiWTp7

The European market prioritizes the safety and efficacy of medical devices. The MDR (EU Regulation 2017/745) governs the entire lifecycle of these devices in Europe, ensuring they function as intended and minimize risks.Achieving MDR Compliance: The Role of StandardsFollowing EU-harmonized standards published in the Official Journal of the European Union is a recommended approach for MDR compliance. These standards provide a roadmap for essential aspects of medical device development. Standards for Risk Management and Biological Evaluation:– EN ISO 14971 outlines a comprehensive risk management process for medical devices.– EN ISO 10993-1 defines biological evaluation and testing within the risk management process. It emphasizes a case-by-case approach, considering factors like contact duration and body part contact to determine appropriate biological evaluation methods. Additional EN ISO 10993 standards delve deeper into specific tests for various biological evaluation endpoints. For instance:– EN ISO 10993-17 and 18 guide toxicological risk assessment and material characterization.– Furthermore, device-specific and clinical investigation standards might also be relevant. By adhering to these standards, manufacturers can promote the safety and effectiveness of their medical devices in the European market. Special Considerations for CMR/ED Phthalates– The MDR restricts the use of certain phthalates, known as CMR/ED phthalates, due to potential health concerns.– Manufacturers should prioritize alternatives whenever possible.– If using a restricted phthalate is essential, a justification based on a thorough risk-benefit analysis is required.– Following these regulations and standards is crucial for ensuring patients have access to safe and effective medical devices. Want to learn more? Our experts can provide further insights into these updates. Check out the tour site at https://lnkd.in/dreiWTp7.